• news

• News in Israel

• health

Pulmonary rehabilitation for corona patients and dental care for children: the drug basket 2021

At the end of three months of discussions, the members of the basket committee decided which patients would receive treatment subsidies.

In the shadow of the Corona, a significant portion of the budget was devoted to building infrastructure to care for Corona patients.

A significant proportion was also attributed to diabetics and children suffering from a rare epilepsy syndrome.

Outdoors - Mammography for women over 40

Tags

• Health basket

• Ministry of Health

• Corona virus

Meirav Cohen

Wednesday, February 10, 2021, 12:45 p.m.

• Share on Facebook

• Share on WhatsApp

• Share on general

• Share on general

• Share on Twitter

• Share on Email

0 comments

• Netanyahu condemns the Hague tribunal's decision: "Anti-Semitism ...

• Suspected murder in Benjamin: woman shot dead, her husband the policeman ...

• Dozens demonstrate against violence against women in Tel ...

• Parents' protest: A convoy of vehicles to Jerusalem demanding the return of ...

• Elrai Price: We will not reach herd immunity, even if everyone ...

• Owners of day care centers and private gardens require an applicable layout ...

• Blue and white election campaign against the Minister of Environmental Protection, ...

• Operation to vaccinate foreign workers against Corona 9.2.21

Netanyahu: "I would like to add at least two weeks to the closure of the borders" (Photo: Shai Makhlouf)

The Drug Basket Committee today (Wednesday) published its recommendations regarding the composition of the basket for 2021. The committee members reached a decision after three months of discussions, and they are now expected to submit their recommendations regarding drugs and technologies to the basket to Health Minister Yuli Edelstein.

The committee members recommended 117 drugs out of 880 submitted at a cost of half a billion shekels.

This year, an additional NIS 50 million was allocated to the committee as part of a summary between the ministers of health and finance.

More than 170,000 Israelis will receive subsidies or funding for drugs and technologies as part of the labels that have been added to the basket.

Full list of drugs for 2021

As expected, the committee's discussions focused on, among other things, helping Corona patients and efforts to deal with the virus' symptoms.

In the shadow of the epidemic, the committee members decided to attach special importance to the issue

of lung rehabilitation

that patients need and it was decided to transfer a one-time supplement of about 33,000 shekels for the establishment of new lung rehabilitation institutes nationwide.

However, the rest of the drug treatment associated with the corona virus will be included in a dedicated budget of the Ministry of Health and not as part of the drug basket.

More on Walla!

NEWS

Roots work: Moran Stoitsky and Michal Amdursky in a surprise challenge

To the full article

The value of the basket - half a billion shekels (Photo: Official website, police spokeswoman - Negev region)

The members of the basket committee paid special attention this year to medicines and technologies for dealing with

diabetes

.

This year it was decided for the first time to price diabetes as a disease, and not each drug separately.

This means increasing accessibility for patients with type 2 diabetes, who work in a combined mechanism.

In addition, they decided to expand the response to the disease with drugs that prevent obesity and blood pressure, thus preventing its deterioration.

As every year, a significant portion of the committee's recommendations addressed

oncology

patients and the

contraindications required to deal with cancer.

The committee members recommended approving drugs and technologies for patients with lung, breast, ovarian and leukemia cancers with a total cost of close to NIS 90 million.

This year, 17 new drugs were introduced to help about 1,700 patients.

Among other things, committee members approved a subsidy for the drug

Abraxane

for the treatment of advanced and non-surgical breast cancer.

There are 42 patients waiting for this drug, at a total cost of NIS 1.7 million per year.

"How can the test be prevented from other women."

Gorodetsky (Photo: courtesy of the photographers)

Despite this, this year too it was decided not to include

mammography

treatments

for women from the age of 40, but only from the age of 50, thus giving up preventive treatment for women at risk of developing breast cancer.

"I am surprised and hard to believe that the decision makers are ignoring women like me who have fallen under the age of 50," said Jenny Gorodetsky, who is currently dealing with the disease.

"It was only thanks to 'One in Nine's awareness raising posts last October that I went to get tested. After various persuasions and excuses the doctor approved me to perform the test that saved my life. I can not understand how it can be prevented from other women."

As for

mental health

, it was decided to

add

only one drug to the basket,

Rexulti

, intended for patients with schizophrenia.

The drug is intended for 710 patients at a cost of 1556 per patient per year.

The total cost is NIS 1.105 million.

A unique drug for heart patients and epileptic syndrome

As part of the discussions of the members of the basket committee, it was decided to recommend the budgeting of unique drugs and new technologies, which will improve the lives of those suffering from various medical problems.

The most expensive drug that entered the basket this year is

Cablivi

, which costs about NIS 560,000 per patient per year, and aims to prevent blindness due to the disease

NMOSD

, which causes a rare and life-threatening autoimmune blood disorder.

Patients with this disease suffer from blood clots in the small blood vessels throughout the body in a way that leads to blindness.

There are 28 patients with this disease in Israel, and the total treatment for them will cost almost NIS 15 million.

In addition, the members of the basket committee recommended a one-time upgrade of an external system for 626 children and youth in Israel who suffer from

deep

deafness

.

The upgrade allows connection to advanced technologies, including smartphones and computers, at a cost of NIS 16 million.

During the year, the effectiveness of the upgrade will be examined and the committee members will determine next year whether to subsidize the system also for graduates over the age of 18.

Another drug that has been approved is "

Forsiga

" which helps

heart patients

.

177,000 people in Israel need it, and now the basket committee has recommended a visa at a cost of NIS 1,200 per patient per year.

Among these patients is also Moshe Schwartz, 67, from Rishon Lezion, who suffers from heart failure after a recent cardiovascular event.

"I was not able to manage my life as I used to and I needed help from those around me, and if that wasn't enough, I also had cardiac arrest and needed resuscitation," Schwartz said.

"I knew my condition was bad, but I did not know how much. So far the treatment for

Forsythe

is only for diabetics and this year it was approved in the health basket for patients with heart failure. I am so happy that the basket committee approved the treatment. It will make it easier for me. From a health and financial point of view, I will not have to buy the drug privately. "

"I knew the situation was bad."

Schwartz (Photo: courtesy of the photographers)

Another drug, "Epidiolx", is intended to help about 350 patients in Israel who suffer from Derva's syndrome - a rare syndrome of epilepsy in children - at a cost of NIS 54,000 per year.

Inbar Debbie from Petah Tikva, the mother of 9-year-old Tair, who suffers from the syndrome, welcomed the decision.

"This is very good news for Tair and for all the children who suffer from the rare syndromes of epilepsy," she said.

"Tair was diagnosed with this rare syndrome at the age of three months as a baby."

"Relative to her young age, Tair went through a lot of suffering and many hospitalizations and unfortunately the hospital was her second and ours home," she continued.

"Finally with a lot of prayers the only hope we have left came true and the drug that has been proven to help reduce seizures significantly was approved and entered the basket. I am happy to hear the news and all hope that the drug will give Tair a good and long life without any seizures."

"A good life without seizures."

Inbar Debbie and her daughter Tair (Photo: Courtesy of those photographed)

NIS 550 million was originally allocated to the basket committee.

Fearing the anomalies, the committee members asked to settle for 520 million, but the Treasury refused.

Also, due to a delay in the decisions of the basket committee - a budget surplus was created for 2021. As a result, the committee members once-budgeted

dental

treatment

for children, including first aid, diagnosis, counseling and preservative treatments, at a cost of NIS 9.7 million.

The dental health of children has so far been through the Ministry of Education, but now it has moved to the box office.

Basket members decided to approve the treatment for a year to know how useful it is.

The HMOs claimed that the treatment of the issue will be priced at a low amount because it is the expenses of the Ministry of Education, but when the treatment goes to the HMOs, they are obliged to publish it and conduct active treatment that will increase the price.

The committee will determine if it will come in regularly only next year after there are data on the high price the treatment has cost the HMOs.

Another issue that has been addressed is screening tests to detect

carriers of genetic diseases

, for 35,000 patients at risk in the amount of 4 million.

The committee members divided the polls into groups, and tests were added to the Bedouin and Karaite populations and among the Ashkenazi Jewish population.

• Share on Facebook

• Share on WhatsApp

• Share on general

• Share on general

• Share on Twitter

• Share on Email

0 comments